Life Sciences

In vitro diagnostics introduces new technologies, sequencing methods, novel software algorithms, and multi-omics approaches to realise the goal of personalized medicine. Next-generation diagnostics has been the backbone of COVID-19-related emergency diagnosis, with an estimated 25% to 30% of revenue during 2020 and early 2021 related to this testin...

08 Mar 2022  |  North America

Global Pharmaceuticals Outlook, 2022

The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders

Infographics

×

Key Issues Addressed

Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...

In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transp...

The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...

The latest issue of the Medical Devices TOE profiles innovations across the innovation ecosystem and the breadth of the medical devices industry. These include innovations from university research labs, start-up companies, corporations and findings from clinical trials. The innovations come from diverse fields such as super-capacitors for implantab...

Cancer immunotherapy and cancer profiling are key areas of growth across the healthcare community. These vital areas will define the future of how cancer is screened, diagnosed, managed, and monitored. With technology areas such as exosome technology being implemented in profiling tumors, a paradigm shift can be brought about in how cancer is detec...

Personalized medicine has brought forth a new avenue for innovation. Currently, genomics is being accelerated into extensive use across drug development and drug discovery. The capability of genomics has brought about the resurgence of biomarkers that could effective patient stratification, ensuring the right drugs are developed to treat a specific...

This edition of the Future Tech TOE primarily encompasses comprehensive analyses of key emerging therapies across multiple sclerosis (MS). The service also includes treatment overviews, clinical pipeline analysis, IP and funding analysis, and emerging innovations across MS therapies. Furthermore, the research features the impact of key technology...

Innovations across health and wellness are improving the quality of diagnosis and prevention. Currently, preventative solutions are gaining a wider acceptance, while solutions like probiotics that supplement the nutrition needs of an individual are important for ensuring a healthy population. However, the current state of diagnosis needs to ensure ...